US Supreme Court rebuffs pharma challenge to Biden-era drug price

Chronological Source Flow

Back

AI Fusion Summary

The Supreme Court declined to hear lawsuits from AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Novartis, and Novo Nordisk challenging the Medicare drug price negotiation program, ending a major legal campaign against the Biden-era policy.